Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy.

Frontiers in oncology·2026

Same author

IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.

Journal for immunotherapy of cancer·2026

Same author

Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.

Oncoimmunology·2026

Same author

The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.

Nature communications·2026

Same author

Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts.

Oncoimmunology·2026

Same author

Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].

European journal of cancer (Oxford, England : 1990)·2026

Search research articles

Related Experiment Video

Updated: Feb 26, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Bayesian inference for biomarker discovery in proteomics: an analytic solution.

Noura Dridi^1,2, Audrey Giremus¹, Jean-Francois Giovannelli³

¹IMS (Univ. Bordeaux, CNRS, BINP), Talence, 33400, France.

EURASIP Journal on Bioinformatics & Systems Biology

|July 16, 2017

Summary

This summary is machine-generated.

This study introduces a novel Bayesian approach for biomarker discovery in proteomics, directly identifying key proteins that indicate disease status. The method optimizes protein subset selection by considering correlations, minimizing errors for accurate biological status determination.

Keywords:

Bayesian approach Biomarker Evidence Hierarchical model Model selection Optimal decision Proteomics Variable selection

More Related Videos

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery

Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery

Published on: April 17, 2012

Related Experiment Videos

Last Updated: Feb 26, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery

Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery

Published on: April 17, 2012

Area of Science:

Proteomics
Biostatistics
Bioinformatics

Background:

Biomarker discovery is crucial for distinguishing pathological from healthy states.
Traditional methods often analyze proteins individually, neglecting inter-protein correlations.
Accurate selection of protein biomarkers requires robust statistical frameworks.

Purpose of the Study:

To develop a Bayesian variable selection method for identifying discriminant protein biomarkers.
To directly seek the optimal partition of proteins into discriminant and non-discriminant sets.
To account for both biological and technical variability in protein concentration data.

Main Methods:

Formulation of the biomarker selection problem as a Bayesian variable selection instance.
Development of two probabilistic models relating biological status to protein concentrations.
Derivation of posterior probabilities for protein partitions, including closed-form solutions and approximations.
Comparison with existing methods like t-test, LASSO, and Battacharyya distance.

Main Results:

A novel Bayesian framework for biomarker discovery in proteomics.
Efficient calculation of posterior probabilities for protein partitions, crucial for optimal decision-making.
Demonstrated effectiveness on both synthetic and real-world mass spectrometry data.
Superior performance compared to several state-of-the-art methods.

Conclusions:

The proposed Bayesian strategy offers an optimal approach to biomarker discovery by considering protein correlations.
The method effectively identifies proteins indicative of biological status, minimizing global mean error.
This work provides a significant advancement in the statistical analysis of proteomic data for clinical applications.